Genetically Enhanced Healthy Tobacco
Property
History
Before revealing its discovery to the world, the consortium carried out a risky commercial operation that no one understood at the time: they paid huge amounts for the cigarette brands from the old multinationals in dire times, such as Phillip Morris, Imperial Tobacco and Altadis, and relaunched those famous cigarette brands in the new therapeutic transgenic format. Once they had obtained their licenses from the WHO, they “discovered” their work to the world on New Year’s Eve 2065, with an unprecedented advertising campaign: carefully selected clips of the most famous scenes in movie history, with their legendary actors posing as smokers and exhaling puffs in delicate pastel shades. Each brand was given a characteristic colour and flavour, sometimes two or three. The reaction of the public was immediate and brought in millions in sales and the resurrection of factories that made ashtrays, lighters, cigarette cases and other accessories related to the outdated culture of cigarettes.
Today, after 50 years of development, the therapeutic specificity of this type of cigarette has reached levels that our ancestors would describe as science fiction: now we can take away a headache or cure a cold by smoking a Marlboro Cherry, a Winston Green or a Chesterfield Blue. In the 90’s the classic cylinder was replaced by a closed head hexagonal prism with microperforations required for certain types of specific therapies.
Characteristics
NICOTROMINE CONTENT (transGenic tobacco): 3 – 3,5 mg / cigarette
THERAPEUTIC CONTENT: Varies accross brands and types
